Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...

Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...

The makers of Oxycontin have agreed to a $7.4 billion ... and the family’s company, Purdue Pharma, will pay nearly $900 million on court approval. Miyares accused Purdue of having a "leading ...

Under the new proposal, like the previous one, members of the Sackler family would also give up ownership of Purdue ... family from civil lawsuits over OxyContin — even though the family ...

Purdue was instrumental in creating the US opioid crisis via aggressive marketing that did not reflect the true addiction ...

Opioid abuse tells a tragic American story since avoidable deaths began in the 1990s. Nearly 700,000 people lost their lives ...

Opioid abuse tells a tragic American story since avoidable deaths began in the 1990s. Nearly 700,000 people lost their lives to overdoses of OxyContin and offshoots of the highly addictive painkiller.

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.

Multiple states have reached a tentative new agreement with the Sackler family, who made billions of dollars marketing OxyContin, the drug that set off the U.S. opioid crisis. New York State Attorney ...

Paul Howe, chief commercial officer at Protega Pharma, discusses recent rule changes and how the industry is impacted by them ...